Your browser doesn't support javascript.
loading
Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.
Zhou, Zilan; Kennell, Carly; Jafari, Mina; Lee, Joo-Youp; Ruiz-Torres, Sasha J; Waltz, Susan E; Lee, Jing-Huei.
Afiliação
  • Zhou Z; Chemical Engineering Program, Department of Biomedical, Environmental, and Chemical Engineering, University of Cincinnati, Cincinnati, OH 45221-0012, USA.
  • Kennell C; Chemical Engineering Program, Department of Biomedical, Environmental, and Chemical Engineering, University of Cincinnati, Cincinnati, OH 45221-0012, USA.
  • Jafari M; Chemical Engineering Program, Department of Biomedical, Environmental, and Chemical Engineering, University of Cincinnati, Cincinnati, OH 45221-0012, USA.
  • Lee JY; Chemical Engineering Program, Department of Biomedical, Environmental, and Chemical Engineering, University of Cincinnati, Cincinnati, OH 45221-0012, USA. Electronic address: jooyoup@gmail.com.
  • Ruiz-Torres SJ; Department of Cancer Biology, College of Medicine University of Cincinnati, Cincinnati, OH 45267-0521, USA.
  • Waltz SE; Department of Cancer Biology, College of Medicine University of Cincinnati, Cincinnati, OH 45267-0521, USA; Research Service, Cincinnati Veteran Hospital Medical Center, Cincinnati, OH 45267-0521, USA.
  • Lee JH; Biomedical Engineering Program, Department of Biomedical, Environmental, and Chemical Engineering, University of Cincinnati, Cincinnati, OH 45221-0012, USA.
Int J Pharm ; 530(1-2): 300-307, 2017 Sep 15.
Article em En | MEDLINE | ID: mdl-28778627
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Sistemas de Liberação de Medicamentos / Nanopartículas / Neoplasias de Mama Triplo Negativas / Cloridrato de Erlotinib Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Sistemas de Liberação de Medicamentos / Nanopartículas / Neoplasias de Mama Triplo Negativas / Cloridrato de Erlotinib Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article